Sernova Biotherapeutics Overview

  • Year Founded
  • 1998

Year Founded

  • Status
  • Public

  • Employees
  • 8

Employees

  • Stock Symbol
  • SVA

Stock Symbol

  • Investments
  • 3

  • Share Price
  • $0.06
  • (As of Friday Closing)

Sernova Biotherapeutics General Information

Description

Sernova Biotherapeutics Inc is a clinical-stage biotechnology company focused on advancing regenerative medicine for the treatment of chronic diseases. The Company's primary asset is its proprietary Cell Pouch, a bio-hybrid organ system designed to enhance the delivery of cell therapy by replicating natural body functions. The Cell Pouch creates a vascularized, organ-like environment that promotes the longevity and functionality of therapeutic cells and ensures containment for retrievability.

Contact Information

Website
www.sernova.com
Formerly Known As
Pheromone Sciences, Sernova Corp
Ownership Status
Publicly Held
Financing Status
Corporation
Corporate Office
  • RPO Central Parkway
  • PO Box 29592
  • Mississauga, Ontario L5A 4H2
  • Canada
+1 (917)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Stock Exchange
TSE
Vertical(s)
Corporate Office
  • RPO Central Parkway
  • PO Box 29592
  • Mississauga, Ontario L5A 4H2
  • Canada
+1 (917)

Sernova Biotherapeutics Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Sernova Biotherapeutics Stock Performance

As of 20-Nov-2026, Sernova Biotherapeutics’s stock price is $0.06. Its current market cap is $23.7M with 378M shares.

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.06 $0.06 $0.06 - $0.14 $23.7M 378M 210K -$0.05

Sernova Biotherapeutics Financials Summary

As of 31-Jul-2026, Sernova Biotherapeutics has a trailing 12-month revenue of null.

In Thousands,
USD
TTM 31-Jul-2026 FY 2025 31-Oct-2025 FY 2024 31-Oct-2024 FY 2023 31-Oct-2023
EV 39,226 45,671 55,290 144,378
Revenue 0 0 0 0
EBITDA (6,485) (10,453) (23,102) (29,652)
Net Income (7,424) (11,223) (23,649) (28,894)
Total Assets 267 547 5,412 15,985
Total Debt 1,844 3,414 410 98
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Sernova Biotherapeutics Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Sernova Biotherapeutics‘s full profile, request access.

Request a free trial

Sernova Biotherapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Sernova Biotherapeutics Inc is a clinical-stage biotechnology company focused on advancing regenerative medicine for the
Drug Discovery
Mississauga, Canada
8 As of 2025

Waltham, MA
 

Madison, WI
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Sernova Biotherapeutics Competitors (42)

One of Sernova Biotherapeutics’s 42 competitors is Viridian Therapeutics, a Formerly VC-backed company based in Waltham, MA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Viridian Therapeutics Formerly VC-backed Waltham, MA
Regenerative Medical Solutions Venture Capital-Backed Madison, WI
Orgenesis Corporation Germantown, MD
Jnana Therapeutics Formerly VC-backed Boston, MA
CalciMedica Formerly VC-backed La Jolla, CA
You’re viewing 5 of 42 competitors. Get the full list »

Sernova Biotherapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Sernova Biotherapeutics Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Sernova Biotherapeutics‘s full profile, request access.

Request a free trial

Sernova Biotherapeutics Investments & Acquisitions (3)

Sernova Biotherapeutics’s most recent deal was a Merger/Acquisition with Seraxis. The deal was made on 08-Sep-2026.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Seraxis 08-Sep-2026 Merger/Acquisition Biotechnology
Converge Biotech (Conformal Coating Technology) 15-Jun-2020 Corporate Asset Purchase Buildings and Property
Mecca Medi-Tech 28-Feb-2000 Merger/Acquisition Special Purpose Acquisition Company (SPAC)
To view Sernova Biotherapeutics’s complete investments and acquisitions history, request access »

Sernova Biotherapeutics ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Healthcare

Industry

Rank

Percentile

Medical Devices

Subindustry

Rank

Percentile

To view Sernova Biotherapeutics’s complete esg history, request access »

Sernova Biotherapeutics FAQs

  • When was Sernova Biotherapeutics founded?

    Sernova Biotherapeutics was founded in 1998.

  • Where is Sernova Biotherapeutics headquartered?

    Sernova Biotherapeutics is headquartered in Mississauga, Canada.

  • What is the size of Sernova Biotherapeutics?

    Sernova Biotherapeutics has 8 total employees.

  • What industry is Sernova Biotherapeutics in?

    Sernova Biotherapeutics’s primary industry is Drug Discovery.

  • Is Sernova Biotherapeutics a private or public company?

    Sernova Biotherapeutics is a Public company.

  • What is Sernova Biotherapeutics’s stock symbol?

    The ticker symbol for Sernova Biotherapeutics is SVA.

  • What is the current stock price of Sernova Biotherapeutics?

    As of 20-Nov-2026 the stock price of Sernova Biotherapeutics is $0.06.

  • What is the current market cap of Sernova Biotherapeutics?

    The current market capitalization of Sernova Biotherapeutics is $23.7M.

  • Who are Sernova Biotherapeutics’s competitors?

    Viridian Therapeutics, Regenerative Medical Solutions, Orgenesis, Jnana Therapeutics, and CalciMedica are some of the 42 competitors of Sernova Biotherapeutics.

  • What is Sernova Biotherapeutics’s annual earnings per share (EPS)?

    Sernova Biotherapeutics’s EPS for 12 months was -$0.05.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process